glp-1 science Science's 2023 Breakthrough of the Year: Weight loss drugs with a real shot at fighting obesity | The Ultimate Guide to GLP-1:
Description
Zepbound (tirzepatide) is a medication approved by the Food and Drug Administration (FDA) to treat obesity and obstructive sleep apnea (OSA) in combination with a reduced-calorie diet and increased exercise
2,13 In more severe cases, complications such as gastroparesis, pancreatitis, and GI bleeding may occur
Curr Opin Endocrinol Diabetes Obes 5(4):252255 Sun EW, Martin AM, Wattchow DA et al (2019) Metformin triggers PYY secretion in human gut mucosa
(2011) 301:R101124
Straw yellow : urine's normal colour
10.1016/j.molmet.2020.101102
